Custom Search
Monday, June 30, 2008
The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities
For people interested in the pharmaceutical industry, I highly recommended you to read a whitepaper. Basically this study report is to provide a roadmap for industry professionals to better understand what the coming industry changes to the business will mean for their careers and where the best pharmaceutical job opportunities will be. More importantly, it is intended to identify the career planning steps that can be taken today that will allow them to capitalize on the many changes coming in the future.
Here, I want to give you highlights of the research:
This report is free to public. Click here to download.
Here, I want to give you highlights of the research:
- Six Future High Growth Areas of the Industry
- Commercialization of Dormant Compounds
- Generic or Biosimilar Versions of Biologics
- Improving the Efficiency of R&D
- Oncology and Central Nervous System (CNS) Disorders Research
- Stratified Medicine and Diagnostics
- Fusion of Pharmaceuticals and Consumer Goods
- Seven Highly-Valued Skill Sets
- Ability to Manage Decentralized Intellectual Capital Resources
- Ability to Work in Joint Ventures and Across Divisions, Cultures and Countries
- Ability to Integrate an Understanding of Intellectual Property Laws, Scientific Expertise and Business Strategy
- Ability to Spur Creativity While Managing Commercially
- Knowledge and Insight on the Decision-Making Dynamics of Payers
- Expertise in the Functioning and Decision-Making of Regulatory Agencies
- Human Resource Skills to Help Transform Pharmaceutical Companies
This report is free to public. Click here to download.
Wednesday, June 25, 2008
FDA Seeking to Fill 1,300 Jobs to Meet Critical Needs
Under a multi-year hiring initiative, the FDA is recruiting for 1,300 medical and science positions to strengthen the agency's public health mission. The FDA has been granted "direct hire" authority to fill these positions quickly with qualified applicants. For the hiring initiative, the FDA is filling jobs in these critical categories:
- Medical Officer
- Pharmacist
- Consumer Safety Officer
- Biologist
- Chemist
- Microbiologist
- Pharmacologist
- Statistician
- Epidemiologist
- Click on a position listed above and follow instructions to apply. (Note: some positions may have multiple locations)
- To help fill 1,300 medical and science positions, the FDA is holding job fairs throughout the United States. View job fair schedule!
- If you have questions, call 888-FDA-HIRE (888-332-4473).
Monday, June 23, 2008
Journal Impact Factor 2007 --- Top 500
Every mid-June, the academia society are getting excited or nervous about newly released journal impact factors. Probably nowadays the impact factor is the most popular and influential measurement to evaluate the people's quality of publications. If you want to know how the impactor for a journal is calculated, please refer to my previous post: What about Journal Impact Factors?
Here are the top 500 journals based on the journal impact factors published this month.
Here are the top 500 journals based on the journal impact factors published this month.
Abbreviated Journal Title | Impact Factor |
CA-CANCER J CLIN | 69.026 |
NEW ENGL J MED | 52.589 |
ANNU REV IMMUNOL | 47.981 |
REV MOD PHYS | 38.403 |
NAT REV MOL CELL BIO | 31.921 |
ANNU REV BIOCHEM | 31.19 |
CELL | 29.887 |
PHYSIOL REV | 29.6 |
NAT REV CANCER | 29.19 |
NATURE | 28.751 |
LANCET | 28.638 |
NAT REV IMMUNOL | 28.3 |
NAT MED | 26.382 |
SCIENCE | 26.372 |
NAT IMMUNOL | 26.218 |
ANNU REV NEUROSCI | 26.077 |
NAT GENET | 25.556 |
JAMA-J AM MED ASSOC | 25.547 |
NAT REV NEUROSCI | 24.52 |
CANCER CELL | 23.858 |
ANNU REV CELL DEV BI | 23.545 |
NAT REV DRUG DISCOV | 23.308 |
NAT BIOTECHNOL | 22.848 |
CHEM REV | 22.757 |
NAT REV GENET | 22.399 |
ANNU REV PHARMACOL | 21.696 |
PROG MATER SCI | 20.846 |
ANNU REV ASTRON ASTR | 20.29 |
PHYS REP | 20.263 |
NAT MATER | 19.782 |
IMMUNITY | 19.266 |
ANNU REV PHYSIOL | 18.875 |
PHARMACOL REV | 18.823 |
ANNU REV PLANT BIOL | 18.712 |
ENDOCR REV | 18.493 |
ANNU REV GENET | 18.302 |
ANNU REV BIOPH BIOM | 17.757 |
NAT CELL BIOL | 17.623 |
BEHAV BRAIN SCI | 17.462 |
CELL METAB | 17.148 |
J CLIN INVEST | 16.915 |
B AM MUS NAT HIST | 16.385 |
ACCOUNTS CHEM RES | 16.214 |
ARCH GEN PSYCHIAT | 15.976 |
CLIN MICROBIOL REV | 15.764 |
J NATL CANCER I | 15.678 |
NAT NEUROSCI | 15.664 |
J EXP MED | 15.612 |
ANN INTERN MED | 15.516 |
J CLIN ONCOL | 15.484 |
NAT METHODS | 15.478 |
TRENDS BIOCHEM SCI | 14.994 |
NAT REV MICROBIOL | 14.959 |
NAT NANOTECHNOL | 14.917 |
TRENDS ECOL EVOL | 14.797 |
GENE DEV | 14.795 |
NAT PHYS | 14.677 |
MICROBIOL MOL BIOL R | 14.629 |
MAT SCI ENG R | 14.4 |
ANNU REV MICROBIOL | 14.362 |
NAT CHEM BIOL | 13.683 |
TRENDS CELL BIOL | 13.527 |
PLOS BIOL | 13.501 |
CURR OPIN CELL BIOL | 13.444 |
ANNU REV MED | 13.415 |
NEURON | 13.41 |
ANNU REV PSYCHOL | 13.4 |
MOL CELL | 13.156 |
CHEM SOC REV | 13.082 |
ANNU REV NUCL PART S | 12.885 |
PROG POLYM SCI | 12.809 |
CIRCULATION | 12.755 |
PLOS MED | 12.601 |
TRENDS NEUROSCI | 12.479 |
DEV CELL | 12.436 |
LANCET ONCOL | 12.247 |
LANCET INFECT DIS | 12.058 |
ALDRICHIM ACTA | 11.929 |
SURF SCI REP | 11.923 |
CYTOKINE GROWTH F R | 11.816 |
GASTROENTEROLOGY | 11.673 |
ANNU REV BIOMED ENG | 11.567 |
REP PROG PHYS | 11.366 |
GENOME RES | 11.224 |
PROG LIPID RES | 11.194 |
AM J HUM GENET | 11.092 |
NAT STRUCT MOL BIOL | 11.085 |
J AM COLL CARDIOL | 11.054 |
MOL PHARM | 11.03 |
PSYCHOL BULL | 10.905 |
MOL PSYCHIATR | 10.9 |
BLOOD | 10.896 |
MASS SPECTROM REV | 10.896 |
ANNU REV PHYTOPATHOL | 10.778 |
HEPATOLOGY | 10.734 |
ANNU REV GENOM HUM G | 10.722 |
ANNU REV ENTOMOL | 10.68 |
CURR BIOL | 10.539 |
IMMUNOL REV | 10.536 |
PROG NEUROBIOL | 10.467 |
ANNU REV ECOL EVOL S | 10.34 |
LANCET NEUROL | 10.169 |
CURR OPIN GENET DEV | 10.15 |
CURR OPIN STRUC BIOL | 10.15 |
ANGEW CHEM INT EDIT | 10.031 |
GUT | 10.015 |
MOL SYST BIOL | 9.954 |
TRENDS GENET | 9.729 |
BRIT MED J | 9.723 |
CIRC RES | 9.721 |
PLANT CELL | 9.653 |
NANO LETT | 9.627 |
TRENDS PHARMACOL SCI | 9.61 |
J CELL BIOL | 9.598 |
P NATL ACAD SCI USA | 9.598 |
ADV PHYS | 9.571 |
TRENDS IMMUNOL | 9.48 |
ANNU REV FLUID MECH | 9.471 |
ANNU REV PHYS CHEM | 9.439 |
MOL CELL PROTEOMICS | 9.425 |
TRENDS COGN SCI | 9.389 |
PLOS PATHOG | 9.336 |
CURR OPIN IMMUNOL | 9.325 |
FEMS MICROBIOL REV | 9.25 |
CURR OPIN PLANT BIOL | 9.189 |
AM J PSYCHIAT | 9.127 |
AM J RESP CRIT CARE | 9.074 |
TRENDS PLANT SCI | 8.995 |
ANNU REV PUBL HEALTH | 8.978 |
CURR OPIN NEUROBIOL | 8.958 |
CRIT REV BIOCHEM MOL | 8.933 |
BIOL REV | 8.833 |
ANN NEUROL | 8.813 |
SYSTEMATIC BIOL | 8.802 |
PLOS GENET | 8.721 |
ANNU REV NUTR | 8.689 |
EMBO J | 8.662 |
BRAIN | 8.568 |
COORDIN CHEM REV | 8.568 |
BIOL PSYCHIAT | 8.456 |
ARCH INTERN MED | 8.391 |
DIABETES | 8.261 |
CELL DEATH DIFFER | 8.254 |
ADV DRUG DELIVER REV | 8.224 |
NAT CLIN PRACT ONCOL | 8.217 |
ECOL LETT | 8.204 |
ADV MATER | 8.191 |
NEUROSCI BIOBEHAV R | 8.147 |
INT REV PHYS CHEM | 8.121 |
ECOL MONOGR | 8.117 |
J ALLERGY CLIN IMMUN | 8.115 |
CLIN PHARMACOL THER | 8.033 |
PHARMACOL THERAPEUT | 7.968 |
EUR HEART J | 7.924 |
ASTROPHYS J SUPPL S | 7.898 |
J AM CHEM SOC | 7.885 |
DIABETES CARE | 7.851 |
OBES REV | 7.821 |
HUM MOL GENET | 7.806 |
PSYCHOL REV | 7.803 |
ANNU REV EARTH PL SC | 7.732 |
PROG RETIN EYE RES | 7.725 |
ARTH RHEUM/AR C RES | 7.677 |
CANCER RES | 7.672 |
ADV CATAL | 7.667 |
NAT PROD REP | 7.667 |
CURR OPIN MICROBIOL | 7.654 |
TRENDS MICROBIOL | 7.618 |
TRENDS BIOTECHNOL | 7.61 |
CURR OPIN CHEM BIOL | 7.588 |
Q REV BIOPHYS | 7.556 |
STEM CELLS | 7.531 |
ADV CANCER RES | 7.524 |
SEMIN CANCER BIOL | 7.51 |
ADV FUNCT MATER | 7.496 |
J NEUROSCI | 7.49 |
EMBO REP | 7.45 |
ANN SURG | 7.446 |
MOL ASPECTS MED | 7.386 |
CURR OPIN BIOTECH | 7.37 |
ADV INSECT PHYSIOL | 7.333 |
DEVELOPMENT | 7.293 |
BBA-REV CANCER | 7.264 |
MED RES REV | 7.264 |
HUM REPROD UPDATE | 7.257 |
TRENDS MOL MED | 7.244 |
ARTERIOSCL THROM VAS | 7.221 |
TRENDS ENDOCRIN MET | 7.195 |
HYPERTENSION | 7.194 |
REV MED VIROL | 7.174 |
J AM SOC NEPHROL | 7.111 |
CAN MED ASSOC J | 7.067 |
SEMIN IMMUNOL | 7 |
NUCLEIC ACIDS RES | 6.954 |
PHYSIOLOGY | 6.954 |
PHYS REV LETT | 6.944 |
LEUKEMIA | 6.924 |
REV GEOPHYS | 6.9 |
J CELL MOL MED | 6.807 |
FASEB J | 6.791 |
DRUG DISCOV TODAY | 6.761 |
PLANT J | 6.751 |
CLIN INFECT DIS | 6.75 |
J HEPATOL | 6.642 |
AM J CLIN NUTR | 6.603 |
GENOME BIOL | 6.589 |
TRAFFIC | 6.533 |
PROG SURF SCI | 6.522 |
CEREB CORTEX | 6.519 |
SEMIN CELL DEV BIOL | 6.482 |
FRONT NEUROENDOCRIN | 6.481 |
BRAIN RES REV | 6.477 |
ONCOGENE | 6.44 |
MOL BIOL EVOL | 6.438 |
DRUG RESIST UPDATE | 6.435 |
AM J TRANSPLANT | 6.423 |
MOL CELL BIOL | 6.42 |
ANN RHEUM DIS | 6.411 |
SMALL | 6.408 |
ASTROPHYS J | 6.405 |
TOP CURR CHEM | 6.394 |
CURR OPIN PHARMACOL | 6.39 |
J CELL SCI | 6.383 |
PLANT PHYSIOL | 6.367 |
AGEING RES REV | 6.365 |
CATAL REV | 6.333 |
STROKE | 6.296 |
CRIT CARE MED | 6.283 |
HUM MUTAT | 6.273 |
ADV IMMUNOL | 6.264 |
BIOMATERIALS | 6.262 |
CLIN CANCER RES | 6.25 |
PLOS COMPUT BIOL | 6.236 |
THORAX | 6.226 |
J SEX MED | 6.199 |
CURR OPIN LIPIDOL | 6.194 |
NEUROPSYCHOPHARMACOL | 6.157 |
HUM BRAIN MAPP | 6.151 |
CARDIOVASC RES | 6.127 |
AM J GASTROENTEROL | 6.101 |
J IMMUNOL | 6.068 |
J COSMOL ASTROPART P | 6.067 |
J INFECT DIS | 6.035 |
MOL BIOL CELL | 6.028 |
NEUROLOGY | 6.014 |
J BONE MINER RES | 6.004 |
ASTRON ASTROPHYS REV | 6 |
MOL INTERV | 6 |
J THROMB HAEMOST | 5.947 |
ADV POLYM SCI | 5.93 |
NANO TODAY | 5.929 |
STUD MYCOL | 5.923 |
BLOOD REV | 5.922 |
J NUCL MED | 5.915 |
GASTROINTEST ENDOSC | 5.888 |
MOL THER | 5.862 |
AGING CELL | 5.854 |
SCHIZOPHRENIA BULL | 5.843 |
AIDS | 5.842 |
RNA | 5.84 |
TRAC-TREND ANAL CHEM | 5.827 |
MIS QUART | 5.826 |
DIABETOLOGIA | 5.822 |
SEMIN LIVER DIS | 5.814 |
NEURO-ONCOLOGY | 5.806 |
NEUROSCIENTIST | 5.796 |
ADV PROTEIN CHEM | 5.786 |
ARCH NEUROL-CHICAGO | 5.783 |
ANN MED | 5.779 |
EMERG INFECT DIS | 5.775 |
PHARMACOGENET GENOM | 5.775 |
HIPPOCAMPUS | 5.745 |
J PHOTOCH PHOTOBIO C | 5.731 |
CHEM BIOL | 5.718 |
SLEEP MED REV | 5.705 |
J PROTEOME RES | 5.675 |
NEOPLASIA | 5.674 |
J HIGH ENERGY PHYS | 5.659 |
ENVIRON HEALTH PERSP | 5.636 |
EUR UROL | 5.634 |
NEUROBIOL AGING | 5.607 |
J BIOL CHEM | 5.581 |
DRUG METAB REV | 5.579 |
RADIOLOGY | 5.561 |
CURR OPIN NEUROL | 5.55 |
J MED GENET | 5.535 |
PHILOS T R SOC B | 5.529 |
HAEMATOL-HEMATOL J | 5.516 |
INT REV CYTOL | 5.506 |
J CLIN ENDOCR METAB | 5.493 |
AM J PATHOL | 5.487 |
ANTIOXID REDOX SIGN | 5.484 |
PROTEOMICS | 5.479 |
CLIN GASTROENTEROL H | 5.465 |
MOL MICROBIOL | 5.462 |
NEUROIMAGE | 5.457 |
BRIT J PSYCHIAT | 5.446 |
EPIDEMIOL REV | 5.429 |
J PATHOL | 5.423 |
CARCINOGENESIS | 5.406 |
BIOESSAYS | 5.402 |
CURR CANCER DRUG TAR | 5.385 |
GLIA | 5.38 |
EUR RESPIR J | 5.349 |
MOL ENDOCRINOL | 5.337 |
J VIROL | 5.332 |
CHEM-EUR J | 5.33 |
CELL MICROBIOL | 5.293 |
ANAL CHEM | 5.287 |
AM J EPIDEMIOL | 5.285 |
EPIDEMIOLOGY | 5.283 |
WHO TECH REP SER | 5.273 |
PROG ENERG COMBUST | 5.269 |
ACM COMPUT SURV | 5.25 |
SEMIN NUCL MED | 5.25 |
MON NOT R ASTRON SOC | 5.249 |
NEW PHYTOL | 5.249 |
PAIN | 5.249 |
J MOL CELL CARDIOL | 5.246 |
CELL MOL LIFE SCI | 5.239 |
BIOTECHNOL ADV | 5.236 |
NEUROTOX RES | 5.234 |
STRUCTURE | 5.231 |
PROG NUCL MAG RES SP | 5.205 |
ENDOCR-RELAT CANCER | 5.193 |
MOL ECOL | 5.169 |
MRS BULL | 5.168 |
INT J EPIDEMIOL | 5.151 |
J CEREBR BLOOD F MET | 5.147 |
CRIT REV TOXICOL | 5.145 |
CHEM COMMUN | 5.141 |
PHYS TODAY | 5.133 |
TRENDS CARDIOVAS MED | 5.129 |
INT J NONLIN SCI NUM | 5.099 |
LAB CHIP | 5.068 |
BIOSENS BIOELECTRON | 5.061 |
J CLIN PSYCHIAT | 5.06 |
BMC BIOL | 5.059 |
ENDOCRINOLOGY | 5.045 |
BIOINFORMATICS | 5.039 |
CRIT REV CL LAB SCI | 5.037 |
PSYCHOTHER PSYCHOSOM | 5.022 |
ASTRON J | 5.019 |
ALLERGY | 5.014 |
PROG BIOPHYS MOL BIO | 5.009 |
FARADAY DISCUSS | 5 |
J COGNITIVE NEUROSCI | 4.997 |
ADV SYNTH CATAL | 4.977 |
PHARMACOGENOMICS J | 4.968 |
TRENDS PARASITOL | 4.961 |
OBES RES | 4.953 |
CURR MED CHEM | 4.944 |
ATHEROSCLEROSIS SUPP | 4.935 |
ENVIRON MICROBIOL | 4.929 |
KIDNEY INT | 4.922 |
AM J MED | 4.907 |
J INTERN MED | 4.901 |
ADV MICROB PHYSIOL | 4.9 |
INT J NEUROPSYCHOPH | 4.895 |
J MED CHEM | 4.895 |
CHEM MATER | 4.883 |
ONCOLOGIST | 4.876 |
ANN ONCOL | 4.875 |
CURR PHARM DESIGN | 4.868 |
ATMOS CHEM PHYS | 4.865 |
J IMMUNOTHER | 4.837 |
GREEN CHEM | 4.836 |
J GEN PHYSIOL | 4.831 |
J INVEST DERMATOL | 4.829 |
ECOLOGY | 4.822 |
J MOL MED-JMM | 4.82 |
FREE RADICAL BIO MED | 4.813 |
GENE THER | 4.812 |
CLIN CHEM | 4.803 |
ORG LETT | 4.802 |
MOL CANCER THER | 4.8 |
GLOBAL CHANGE BIOL | 4.786 |
PLOS CLIN TRIALS | 4.774 |
ANNU REV MATER RES | 4.765 |
NAT CLIN PRACT NEPHR | 4.764 |
J CONTROL RELEASE | 4.756 |
CURR OPIN INFECT DIS | 4.754 |
SOC NEUROSCI | 4.75 |
NAT CLIN PRACT CARD | 4.743 |
ACS CHEM BIOL | 4.741 |
J CATAL | 4.737 |
REJUV RES | 4.728 |
MEDICINE | 4.721 |
J NEUROPATH EXP NEUR | 4.718 |
DEV BIOL | 4.714 |
INFLAMM BOWEL DIS | 4.705 |
SOFT MATTER | 4.703 |
LASER PART BEAMS | 4.696 |
PHYS REV D | 4.696 |
Q J EXP PSYCHOL-B | 4.667 |
INT J IMMUNOPATH PH | 4.665 |
EUR J IMMUNOL | 4.662 |
BRAIN BEHAV IMMUN | 4.659 |
AUTOPHAGY | 4.657 |
J AM ACAD CHILD PSY | 4.655 |
COCHRANE DB SYST REV | 4.654 |
APPL CATAL B-ENVIRON | 4.651 |
CONTEMP PHYS | 4.651 |
NUCL PHYS B | 4.645 |
CANCER EPIDEM BIOMAR | 4.642 |
CLADISTICS | 4.642 |
BRIT J CANCER | 4.635 |
CANCER | 4.632 |
CRIT REV ONCOL HEMAT | 4.632 |
BIOPHYS J | 4.627 |
CURR MOL MED | 4.624 |
INTENS CARE MED | 4.623 |
OPHTHALMOLOGY | 4.621 |
CRIT REV ENV SCI TEC | 4.615 |
CURR TOP DEV BIOL | 4.615 |
AM J RESP CELL MOL | 4.608 |
ADV INORG CHEM | 4.6 |
ANESTHESIOLOGY | 4.596 |
J PHYSIOL-LONDON | 4.58 |
PROG HISTOCHEM CYTO | 4.571 |
INT J CANCER | 4.555 |
ANTIVIR THER | 4.547 |
AM NAT | 4.543 |
ANN FAM MED | 4.542 |
CANCER TREAT REV | 4.539 |
GENE CHROMOSOME CANC | 4.532 |
INT J PLASTICITY | 4.516 |
CNS DRUGS | 4.514 |
EVOLUTION | 4.502 |
PLANT CELL ENVIRON | 4.497 |
BRIT J HAEMATOL | 4.49 |
CURR DRUG METAB | 4.49 |
LAB INVEST | 4.479 |
CRIT REV PLANT SCI | 4.477 |
PEDIATRICS | 4.473 |
J MOL BIOL | 4.472 |
J PHYSIOL PHARMACOL | 4.466 |
CURR GENE THER | 4.455 |
EUR J CANCER | 4.454 |
BREAST CANCER RES TR | 4.453 |
J NEUROCHEM | 4.451 |
PROG NUCLEIC ACID RE | 4.448 |
BIPOLAR DISORD | 4.442 |
EXERC IMMUNOL REV | 4.438 |
GLOBAL ECOL BIOGEOGR | 4.435 |
J CHILD PSYCHOL PSYC | 4.432 |
EUR NEUROPSYCHOPHARM | 4.43 |
J ECOL | 4.422 |
PSYCHONEUROENDOCRINO | 4.422 |
AM J PHYSIOL-RENAL | 4.416 |
BRIEF BIOINFORM | 4.415 |
NAT CLIN PRACT GASTR | 4.415 |
JAIDS-J ACQ IMM DEF | 4.412 |
CURR TOP MICROBIOL | 4.411 |
MACROMOLECULES | 4.411 |
TISSUE ENG | 4.409 |
CURR OPIN HEMATOL | 4.408 |
ANTIMICROB AGENTS CH | 4.39 |
BIOCONJUGATE CHEM | 4.384 |
NEUROBIOL DIS | 4.377 |
BBA-MOL CELL RES | 4.374 |
J SOIL SEDIMENT | 4.373 |
BREAST CANCER RES | 4.371 |
J HYPERTENS | 4.364 |
ENVIRON SCI TECHNOL | 4.363 |
MAYO CLIN PROC | 4.362 |
CURR OPIN COLLOID IN | 4.354 |
MUTAT RES-REV MUTAT | 4.353 |
SLEEP | 4.342 |
J MATER CHEM | 4.339 |
NAT CLIN PRACT NEURO | 4.339 |
CELL CALCIUM | 4.338 |
CHROMOSOMA | 4.337 |
J LIPID RES | 4.336 |
GLOBAL BIOGEOCHEM CY | 4.335 |
BASIC RES CARDIOL | 4.333 |
HUM GENE THER | 4.33 |
CURR TOP MED CHEM | 4.325 |
MOL CANCER RES | 4.317 |
EARTH-SCI REV | 4.31 |
J CHEM THEORY COMPUT | 4.308 |
MECH AGEING DEV | 4.308 |
BRIT J SURG | 4.304 |
J COMPUT CHEM | 4.297 |
INT J RADIAT ONCOL | 4.29 |
PIGM CELL RES | 4.288 |
ATHEROSCLEROSIS | 4.287 |
MODERN PATHOL | 4.286 |
OBSTET GYNECOL | 4.282 |
NEUROGENETICS | 4.281 |
MOL PLANT MICROBE IN | 4.275 |
ADV PARASIT | 4.27 |
FRONT ECOL ENVIRON | 4.269 |
CARBON | 4.26 |
ASTRON ASTROPHYS | 4.259 |
APPL SPECTROSC REV | 4.25 |
CRIT REV BIOTECHNOL | 4.25 |
BIOMOL ENG | 4.246 |
CANCER METAST REV | 4.241 |
SCHIZOPHR RES | 4.24 |
Thursday, June 12, 2008
Career Path for Clinical Molecular Genetics---Part II
Second, after the two-year ABMG (American Board of Medical Genetics)-accredited fellowship, the trainee should be ready for the certification of ABMG. The key steps for the certification process I summarize here:
- The training program director must submit to the ABMG Administrative Office documents verifying the training of each medical genetics trainee planning to seek ABMG certification.
- The ABMG Credentials Committee will review the documents. If all credentialing requirements have been satisfied in one or more specialty areas and all application review fees have been paid. The active candidate status will be granted to the trainee, who is eligible to sit the certifying examination(s).
- Take the certifying exam! The examination will be computer-based, which is administered at Thomson Prometric test centers located in the United Sates and its territories.
Another nice thing is when I search indeed.com using the key word: clinical molecular genetics+Ph.D, I saw the increasing recruitment over time (see the figure above) and the stunning average salary: $98,000!
Subscribe to Posts [Atom]